AZD0780
AZD0780 (EX-A6975) is an oral small molecule PCSK9 inhibitor being developed by AstraZeneca as a first-in-class treatment for patients with dyslipidemia that is uncontrolled with statins alone.
Product Specifications
CAS Number
2455427-91-3
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
414.41
Molecular Formula
C20H20F2N6O2
Notes
Research use only, not for human use.
Receptor
Others
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS2115702-01 0.1 mL
HRP-Linked Polyclonal Antibody to Beta-Endorphin (bEP)
Sign In for Pricing
View Details MBS2115702-02 0.2 mL
HRP-Linked Polyclonal Antibody to Beta-Endorphin (bEP)
Sign In for Pricing
View Details MBS2115702-03 0.5 mL
HRP-Linked Polyclonal Antibody to Beta-Endorphin (bEP)
Sign In for Pricing
View Details MBS2115702-04 1 mL
HRP-Linked Polyclonal Antibody to Beta-Endorphin (bEP)
Sign In for Pricing
View Details